MUX Form 4/A: CEO exercises options at $1.25 and sells shares at $14.35 avg
Rhea-AI Filing Summary
Robert Ross McEwen, Chairman and CEO of McEwen Inc. (MUX), filed an amended Form 4 reporting matched option exercise and stock sale transactions on 09/19/2025. He exercised a stock option with a $1.25 exercise price to acquire 50,000 shares and sold 50,000 shares at a weighted-average price of $14.3467, resulting in 50,000 shares beneficially owned after the transactions. The filing corrects prior reporting to reflect the issuer's 10-for-1 reverse split effective 07/28/2022. The option vested in three equal annual installments beginning 09/29/2021. The amendment is signed 09/29/2025.
Positive
- Corrective amendment issued to align option and share counts with the 10-for-1 reverse split, improving reporting accuracy
- Insider disclosed vesting details for the option (vested in three equal annual installments starting 09/29/2021) which increases transparency
Negative
- Insider sale of 50,000 shares at a weighted-average price of $14.3467, representing realized disposition of previously held shares
Insights
TL;DR: Insider exercised options and sold an equal number of shares, leaving a net unchanged position of 50,000 shares.
The filing shows a simultaneous exercise of stock options at $1.25 and sale of the same number of shares at a weighted-average of $14.3467, consistent with routine liquidity transactions following option exercise. The amendment corrects holdings to reflect a prior 10-for-1 reverse split, improving accuracy of reported share counts. This disclosure is material for transparency but does not, by itself, indicate a change in control or strategic direction.
TL;DR: The amendment clarifies beneficial ownership after corporate action; insider remains a director and 10% owner.
The report confirms Mr. McEwen's roles as Chairman, CEO, director and 10% owner while documenting corrective reporting tied to a prior reverse split. The vesting schedule note and signature date satisfy Section 16 reporting requirements. From a governance perspective, the disclosure maintains regulatory compliance and corrects historical reporting errors, which is important for stakeholder record-keeping.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 50,000 | $0.00 | -- |
| Exercise | Common Stock | 50,000 | $1.25 | $63K |
| Sale | Common Stock | 50,000 | $14.3467 | $717K |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. Mr. McEwen sold shares in multiple transactions at prices ranging from $13.69 to $14.6625. Mr. McEwen undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The option vested in three equal annual installments, beginning September 29, 2021.